Journal
WORLD JOURNAL OF CLINICAL CASES
Volume 10, Issue 16, Pages 5515-5517Publisher
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.12998/wjcc.v10.i16.5515
Keywords
Depression; Electroconvulsive therapy; Major depressive disorder; Somatic cell therapy
Categories
Funding
- Curriculum Reform Project of Taizhou University [xkg2021087]
Ask authors/readers for more resources
Major depressive disorder is a common and serious neuropsychiatric disorder, affecting over 350 million people worldwide. Electroconvulsive therapy, the oldest and most effective treatment, can modify structural network changes and affect neuroinflammatory responses in patients with major depressive disorder.
Major depressive disorder is a serious and common neuropsychiatric disorder that affects more than 350 million people worldwide. Electroconvulsive therapy is the oldest and most effective treatment available for the treatment of severe major depressive disorder. Electroconvulsive therapy modifies structural network changes in patients with major depressive disorder and schizophrenia. And it can also affect neuroinflammatory responses and may have neuroprotective effects. Electroconvulsive therapy plays an irreplaceable role in the treatment of major depressive disorder.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available